226 related articles for article (PubMed ID: 24024905)
1. Pancreatic cancer.
Güngör C; Hofmann BT; Wolters-Eisfeld G; Bockhorn M
Br J Pharmacol; 2014 Feb; 171(4):849-58. PubMed ID: 24024905
[TBL] [Abstract][Full Text] [Related]
2. Involvement of midkine in neuroblastoma tumourigenesis.
Kishida S; Kadomatsu K
Br J Pharmacol; 2014 Feb; 171(4):896-904. PubMed ID: 24116381
[TBL] [Abstract][Full Text] [Related]
3. Structure and function of midkine as the basis of its pharmacological effects.
Muramatsu T
Br J Pharmacol; 2014 Feb; 171(4):814-26. PubMed ID: 23992440
[TBL] [Abstract][Full Text] [Related]
4. Extracellular vesicles derived from pancreatic cancer cells are enriched in the growth factor Midkine.
Casari I; Emmanouilidi A; Domenichini A; Falasca M
Adv Biol Regul; 2022 Jan; 83():100857. PubMed ID: 34916167
[TBL] [Abstract][Full Text] [Related]
5. Midkine as a regulator of B cell survival in health and disease.
Cohen S; Shachar I
Br J Pharmacol; 2014 Feb; 171(4):888-95. PubMed ID: 24111754
[TBL] [Abstract][Full Text] [Related]
6. Targeting midkine and pleiotrophin signalling pathways in addiction and neurodegenerative disorders: recent progress and perspectives.
Herradón G; Pérez-García C
Br J Pharmacol; 2014 Feb; 171(4):837-48. PubMed ID: 23889475
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of midkine in cardiovascular disease.
Kadomatsu K; Bencsik P; Görbe A; Csonka C; Sakamoto K; Kishida S; Ferdinandy P
Br J Pharmacol; 2014 Feb; 171(4):936-44. PubMed ID: 24286213
[TBL] [Abstract][Full Text] [Related]
8. The midkine family of growth factors: diverse roles in nervous system formation and maintenance.
Winkler C; Yao S
Br J Pharmacol; 2014 Feb; 171(4):905-12. PubMed ID: 24125182
[TBL] [Abstract][Full Text] [Related]
9. Midkine: an emerging target of drug development for treatment of multiple diseases.
Muramatsu T; Kadomatsu K
Br J Pharmacol; 2014 Feb; 171(4):811-3. PubMed ID: 24460672
[TBL] [Abstract][Full Text] [Related]
10. Midkine in host defence.
Gela A; Jovic S; Nordin SL; Egesten A
Br J Pharmacol; 2014 Feb; 171(4):859-69. PubMed ID: 24024937
[TBL] [Abstract][Full Text] [Related]
11. The multifunctional growth factor midkine promotes proliferation and migration in pancreatic cancer.
Rawnaq T; Dietrich L; Wolters-Eisfeld G; Uzunoglu FG; Vashist YK; Bachmann K; Simon R; Izbicki JR; Bockhorn M; Güngör C
Mol Cancer Res; 2014 May; 12(5):670-80. PubMed ID: 24567526
[TBL] [Abstract][Full Text] [Related]
12. Midkine promoter-based conditionally replicative adenovirus therapy for midkine-expressing human pancreatic cancer.
Toyoda E; Doi R; Kami K; Mori T; Ito D; Koizumi M; Kida A; Nagai K; Ito T; Masui T; Wada M; Tagawa M; Uemoto S
J Exp Clin Cancer Res; 2008 Aug; 27(1):30. PubMed ID: 18717994
[TBL] [Abstract][Full Text] [Related]
13. Notch signaling in pancreatic cancer: oncogene or tumor suppressor?
Avila JL; Kissil JL
Trends Mol Med; 2013 May; 19(5):320-7. PubMed ID: 23545339
[TBL] [Abstract][Full Text] [Related]
14. The role of midkine in skeletal remodelling.
Liedert A; Schinke T; Ignatius A; Amling M
Br J Pharmacol; 2014 Feb; 171(4):870-8. PubMed ID: 24102259
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic cancer tumour initiating cells: the molecular regulation and therapeutic values.
Ni X; Long J; Cen P; Chen L; Yang J; Li M
J Cell Mol Med; 2012 May; 16(5):988-94. PubMed ID: 22050663
[TBL] [Abstract][Full Text] [Related]
16. Lunatic Fringe is a potent tumor suppressor in Kras-initiated pancreatic cancer.
Zhang S; Chung WC; Xu K
Oncogene; 2016 May; 35(19):2485-95. PubMed ID: 26279302
[TBL] [Abstract][Full Text] [Related]
17. The expression and function of midkine in the vertebrate retina.
Gramage E; Li J; Hitchcock P
Br J Pharmacol; 2014 Feb; 171(4):913-23. PubMed ID: 24460673
[TBL] [Abstract][Full Text] [Related]
18. Targeting notch to eradicate pancreatic cancer stem cells for cancer therapy.
Wang Z; Ahmad A; Li Y; Azmi AS; Miele L; Sarkar FH
Anticancer Res; 2011 Apr; 31(4):1105-13. PubMed ID: 21508353
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic Cancer Stem Cells and Therapeutic Approaches.
Ercan G; Karlitepe A; Ozpolat B
Anticancer Res; 2017 Jun; 37(6):2761-2775. PubMed ID: 28551612
[TBL] [Abstract][Full Text] [Related]
20. Emerging pathways and future targets for the molecular therapy of pancreatic cancer.
Vaccaro V; Melisi D; Bria E; Cuppone F; Ciuffreda L; Pino MS; Gelibter A; Tortora G; Cognetti F; Milella M
Expert Opin Ther Targets; 2011 Oct; 15(10):1183-96. PubMed ID: 21819318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
